Global Pre-Menstrual Syndrome Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Pre-Menstrual Syndrome Market Overview

• 1.1 Product Overview and Scope of Pre-Menstrual Syndrome
• 1.2 Classification of Pre-Menstrual Syndrome by Types
  • 1.2.1 Global Pre-Menstrual Syndrome Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Pre-Menstrual Syndrome Revenue Market Share by Types in 2018
  • 1.2.3 Analgesics (Pain Killers)
  • 1.2.4 Oral Contraceptive Pills (OCPs)
  • 1.2.5 Gonadotropin-Releasing Hormone (GnRH)
  • 1.2.6 Antidepressants
  • 1.2.7 Ovarian Suppressors
  • 1.2.8 Diuretics
  • 1.2.9 Benzodiazepines
• 1.3 Global Pre-Menstrual Syndrome Market by Application
  • 1.3.1 Global Pre-Menstrual Syndrome Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Hospitals
  • 1.3.3 Clinic
  • 1.3.4 Others
• 1.4 Global Pre-Menstrual Syndrome Market by Regions
  • 1.4.1 Global Pre-Menstrual Syndrome Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Pre-Menstrual Syndrome Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Pre-Menstrual Syndrome Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Pre-Menstrual Syndrome Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Pre-Menstrual Syndrome Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Pre-Menstrual Syndrome Status and Prospect (2014-2024)
• 1.5 Global Market Size of Pre-Menstrual Syndrome (2014-2024)

2 Company Profiles

• 2.1 MetP Pharma AG
  • 2.1.1 Business Overview
  • 2.1.2 Pre-Menstrual Syndrome Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 MetP Pharma AG Pre-Menstrual Syndrome Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 Pherin Pharmaceuticals, Inc.
  • 2.2.1 Business Overview
  • 2.2.2 Pre-Menstrual Syndrome Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 Pherin Pharmaceuticals, Inc. Pre-Menstrual Syndrome Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 DEKK-TEC, Inc.
  • 2.3.1 Business Overview
  • 2.3.2 Pre-Menstrual Syndrome Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 DEKK-TEC, Inc. Pre-Menstrual Syndrome Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 Bayer, Inc.
  • 2.4.1 Business Overview
  • 2.4.2 Pre-Menstrual Syndrome Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 Bayer, Inc. Pre-Menstrual Syndrome Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 Alva-Amco Pharmacal Cos., Inc.
  • 2.5.1 Business Overview
  • 2.5.2 Pre-Menstrual Syndrome Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Alva-Amco Pharmacal Cos., Inc. Pre-Menstrual Syndrome Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 Chattem, Inc. (Sanofi)
  • 2.6.1 Business Overview
  • 2.6.2 Pre-Menstrual Syndrome Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 Chattem, Inc. (Sanofi) Pre-Menstrual Syndrome Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 Novartis AG
  • 2.7.1 Business Overview
  • 2.7.2 Pre-Menstrual Syndrome Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 Novartis AG Pre-Menstrual Syndrome Revenue, Gross Margin and Market Share (2017-2018)
• 2.8 McNeil Consumer Healthcare
  • 2.8.1 Business Overview
  • 2.8.2 Pre-Menstrual Syndrome Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 McNeil Consumer Healthcare Pre-Menstrual Syndrome Revenue, Gross Margin and Market Share (2017-2018)
• 2.9 G. R. Lane Health Products Ltd
  • 2.9.1 Business Overview
  • 2.9.2 Pre-Menstrual Syndrome Type and Applications
    • 2.9.2.1 Product A
    • 2.9.2.2 Product B
  • 2.9.3 G. R. Lane Health Products Ltd Pre-Menstrual Syndrome Revenue, Gross Margin and Market Share (2017-2018)
• 2.10 Umecrine Mood AB
  • 2.10.1 Business Overview
  • 2.10.2 Pre-Menstrual Syndrome Type and Applications
    • 2.10.2.1 Product A
    • 2.10.2.2 Product B
  • 2.10.3 Umecrine Mood AB Pre-Menstrual Syndrome Revenue, Gross Margin and Market Share (2017-2018)
• 2.11 GlaxoSmithKline Plc
  • 2.11.1 Business Overview
  • 2.11.2 Pre-Menstrual Syndrome Type and Applications
    • 2.11.2.1 Product A
    • 2.11.2.2 Product B
  • 2.11.3 GlaxoSmithKline Plc Pre-Menstrual Syndrome Revenue, Gross Margin and Market Share (2017-2018)

3 Global Pre-Menstrual Syndrome Market Competition, by Players

• 3.1 Global Pre-Menstrual Syndrome Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Pre-Menstrual Syndrome Players Market Share
  • 3.2.2 Top 10 Pre-Menstrual Syndrome Players Market Share
• 3.3 Market Competition Trend

4 Global Pre-Menstrual Syndrome Market Size by Regions

• 4.1 Global Pre-Menstrual Syndrome Revenue and Market Share by Regions
• 4.2 North America Pre-Menstrual Syndrome Revenue and Growth Rate (2014-2019)
• 4.3 Europe Pre-Menstrual Syndrome Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Pre-Menstrual Syndrome Revenue and Growth Rate (2014-2019)
• 4.5 South America Pre-Menstrual Syndrome Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Pre-Menstrual Syndrome Revenue and Growth Rate (2014-2019)

5 North America Pre-Menstrual Syndrome Revenue by Countries

• 5.1 North America Pre-Menstrual Syndrome Revenue by Countries (2014-2019)
• 5.2 USA Pre-Menstrual Syndrome Revenue and Growth Rate (2014-2019)
• 5.3 Canada Pre-Menstrual Syndrome Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Pre-Menstrual Syndrome Revenue and Growth Rate (2014-2019)

6 Europe Pre-Menstrual Syndrome Revenue by Countries

• 6.1 Europe Pre-Menstrual Syndrome Revenue by Countries (2014-2019)
• 6.2 Germany Pre-Menstrual Syndrome Revenue and Growth Rate (2014-2019)
• 6.3 UK Pre-Menstrual Syndrome Revenue and Growth Rate (2014-2019)
• 6.4 France Pre-Menstrual Syndrome Revenue and Growth Rate (2014-2019)
• 6.5 Russia Pre-Menstrual Syndrome Revenue and Growth Rate (2014-2019)
• 6.6 Italy Pre-Menstrual Syndrome Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Pre-Menstrual Syndrome Revenue by Countries

• 7.1 Asia-Pacific Pre-Menstrual Syndrome Revenue by Countries (2014-2019)
• 7.2 China Pre-Menstrual Syndrome Revenue and Growth Rate (2014-2019)
• 7.3 Japan Pre-Menstrual Syndrome Revenue and Growth Rate (2014-2019)
• 7.4 Korea Pre-Menstrual Syndrome Revenue and Growth Rate (2014-2019)
• 7.5 India Pre-Menstrual Syndrome Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Pre-Menstrual Syndrome Revenue and Growth Rate (2014-2019)

8 South America Pre-Menstrual Syndrome Revenue by Countries

• 8.1 South America Pre-Menstrual Syndrome Revenue by Countries (2014-2019)
• 8.2 Brazil Pre-Menstrual Syndrome Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Pre-Menstrual Syndrome Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Pre-Menstrual Syndrome Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Pre-Menstrual Syndrome by Countries

• 9.1 Middle East and Africa Pre-Menstrual Syndrome Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Pre-Menstrual Syndrome Revenue and Growth Rate (2014-2019)
• 9.3 UAE Pre-Menstrual Syndrome Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Pre-Menstrual Syndrome Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Pre-Menstrual Syndrome Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Pre-Menstrual Syndrome Revenue and Growth Rate (2014-2019)

10 Global Pre-Menstrual Syndrome Market Segment by Type

• 10.1 Global Pre-Menstrual Syndrome Revenue and Market Share by Type (2014-2019)
• 10.2 Global Pre-Menstrual Syndrome Market Forecast by Type (2019-2024)
• 10.3 Analgesics (Pain Killers) Revenue Growth Rate (2014-2024)
• 10.4 Oral Contraceptive Pills (OCPs) Revenue Growth Rate (2014-2024)
• 10.5 Gonadotropin-Releasing Hormone (GnRH) Revenue Growth Rate (2014-2024)
• 10.6 Antidepressants Revenue Growth Rate (2014-2024)
• 10.7 Ovarian Suppressors Revenue Growth Rate (2014-2024)
• 10.8 Diuretics Revenue Growth Rate (2014-2024)
• 10.9 Benzodiazepines Revenue Growth Rate (2014-2024)

11 Global Pre-Menstrual Syndrome Market Segment by Application

• 11.1 Global Pre-Menstrual Syndrome Revenue Market Share by Application (2014-2019)
• 11.2 Pre-Menstrual Syndrome Market Forecast by Application (2019-2024)
• 11.3 Hospitals Revenue Growth (2014-2019)
• 11.4 Clinic Revenue Growth (2014-2019)
• 11.5 Others Revenue Growth (2014-2019)

12 Global Pre-Menstrual Syndrome Market Size Forecast (2019-2024)

• 12.1 Global Pre-Menstrual Syndrome Market Size Forecast (2019-2024)
• 12.2 Global Pre-Menstrual Syndrome Market Forecast by Regions (2019-2024)
• 12.3 North America Pre-Menstrual Syndrome Revenue Market Forecast (2019-2024)
• 12.4 Europe Pre-Menstrual Syndrome Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Pre-Menstrual Syndrome Revenue Market Forecast (2019-2024)
• 12.6 South America Pre-Menstrual Syndrome Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Pre-Menstrual Syndrome Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology